MaryClareSpellmanMD

PubMed

• 18 citations
  Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials.
  Claudia Zeidler, Manuel P. Pereira, Matthias Augustin, Mary C. Spellman, Sonja Ständer> ;Acta Dermato-Venereologica. 2021 Feb 17
• 32 citations
  Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
  David M. Pariser, Jerry Bagel, Mark Lebwohl, Gil Yosipovitch, Elaine Chien, Mary C. Spellman> ;Journal of the American Academy of Dermatology. 2020 Jun 1
• 46 citations
  Diagnostic and treatment algorithm for chronic nodular prurigo.
  Sarina B. Elmariah, Claudia Zeidler, Mary C. Spellman, Sonja Ständer> ;Journal of the American Academy of Dermatology. 2020 Feb 1
• 14 citations
  The NK1 receptor antagonist serlopitant for treatment of chronic pruritus
  Sonja Ständer, Mary C. Spellman, Paul Kwon, Gil Yosipovitch> ;Expert Opinion on Investigational Drugs. 2019 Jul 4
• 320 citations
  Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children...
  Amy S. Paller, Wynnis L. Tom, Mark Lebwohl, Robin L. Blumenthal, Mark Boguniewicz, Robert S. Call, Lawrence F. Eichenfield, Douglass W. Forsha, William C. Rees, Eric L...> ;Journal of the American Academy of Dermatology. 2016 Sep 1
• 61 citations
  Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects
  Jill A. Poole, Jianfeng Meng, Mitchell Reff, Mary C. Spellman, Lanny J. Rosenwasser> ;The Journal of Allergy and Clinical Immunology. 2005 Oct 1
• 55 citations
  The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-Type Psoriasis of Nonscalp Regions:
  Alice B. Gottlieb, Rosanne Odom Ford, Mary C. Spellman> ;Journal of Cutaneous Medicine and Surgery. 2003 Apr 22
• 159 citations
  Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
  Alice B. Gottlieb, James G. Krueger, Ross Bright, Mark Ling, Mark Lebwohl, Sewon Kang, Steve R. Feldman, Mary C. Spellman, Knut M. Wittkowski, Hans D. Ochs, Paula Jard...> ;Journal of the American Academy of Dermatology. 2000 Mar 1
• 19 citations
  Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne
  Mary C. Spellman, Stephanie H. Pincus> ;Clinical Therapeutics. 1998 Jul 1
• 65 citations
  Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations
  Erik O. Gilbertson, Mary C. Spellman, Daniel Piacquadio, Mim I. Mulford> ;Journal of the American Academy of Dermatology. 1998 Feb 1
• 19 citations
  Oral 2-chlorodeoxyadenosine in psoriatic
  Barry Eibschutz, Stephen M. Baird, Michael H. Weisman, Diane Amox, Mary C. Spellman, Daniel Piacquadio, Carlos J. Carrera, Dennis A. Carson> ;Arthritis and Rheumatism. 1995 Nov 1
• 5 citations
  Obesity and female androgenic alopecia: a cause and an effect?
  Daniel Piacquadio, Farhad S. Rad, Mary C. Spellman, Kathryn A. Hollenbach> ;Journal of the American Academy of Dermatology. 1994 Jun 1
• Bioavailability of clobetasol propionate in different vehicles.
  Franz, T. J., Lehman, P. A., Feldman, S. R., Spellman, M. C.> ;Skin Pharmacol Appl Skin Physiol. 2003 Jun 05
• Join now to see all

Lectures

• Late-breaking Research: Clinical Trials 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019